Rede D'Or São Luiz S.A. (BVMF:RDOR3)

Brazil flag Brazil · Delayed Price · Currency is BRL
38.43
0.00 (0.00%)
Apr 28, 2026, 5:07 PM GMT-3
22.31%
Market Cap 84.79B
Revenue (ttm) 55.73B
Net Income (ttm) 4.69B
Shares Out 2.21B
EPS (ttm) 2.12
PE Ratio 18.09
Forward PE 16.40
Dividend 4.29 (11.17%)
Ex-Dividend Date Mar 27, 2026
Volume 4,261,300
Average Volume 10,006,385
Open 37.89
Previous Close 38.43
Day's Range 37.73 - 38.61
52-Week Range 31.17 - 48.41
Beta 0.82
RSI 44.33
Earnings Date May 6, 2026

About Rede D'Or São Luiz

Rede D'Or São Luiz S.A. engages in the provision of hospital services in Brazil. The company provides assistance and hospitality concept services; and supplementary services, such as blood bank, dialysis, and outpatient clinics with various specialties. It also offers health insurance and plan, as well as dental plans for small, medium, and large-sized companies; individual plans; individual and group life, travel, credit life, endowment, as well as personal, individual, and group accident insurance products; and pension risk. In addition, the ... [Read more]

Sector Healthcare
Founded 1977
Employees 31,400
Stock Exchange Brazil Stock Exchange
Ticker Symbol RDOR3
Full Company Profile

Financial Performance

In 2025, Rede D'Or São Luiz's revenue was 55.73 billion, an increase of 10.19% compared to the previous year's 50.57 billion. Earnings were 4.69 billion, an increase of 21.87%.

Financial Statements

News

Rede d or Sao Luiz SA (BSP:RDOR3) Q4 2025 Earnings Call Highlights: Record Growth and Strategic ...

Rede d or Sao Luiz SA (BSP:RDOR3) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Insights

2 months ago - GuruFocus

Q4 2025 Rede D'Or Sao Luiz SA Earnings Call (English, Portuguese) Transcript

Q4 2025 Rede D'Or Sao Luiz SA Earnings Call (English, Portuguese) Transcript

2 months ago - GuruFocus

Rede D'Or São Luiz Earnings Call Transcript: Q4 2025

Record 2025 results with 27% revenue growth, strong EBITDA, and improved loss ratios. Operational expansion, disciplined capital allocation, and innovation drove performance, while one-off provisioning impacted Q4. Outlook for 2026 remains positive.

2 months ago - Transcripts

Rede D'Or São Luiz Earnings Call Transcript: Q3 2025

Q3 2025 saw double-digit revenue and profit growth, record hospital occupancy, and strong expansion in oncology and SulAmérica's client base. Operational efficiency, margin expansion, and disciplined capital allocation remain key priorities amid a competitive market.

6 months ago - Transcripts

Rede D'Or São Luiz Earnings Call Transcript: Q2 2025

Revenue grew 11.5% year-over-year in Q2 2025, with strong EBITDA and net income growth, robust cash generation, and reduced leverage. Operational expansion and digital initiatives are driving efficiency, while SulAmérica continues to grow its beneficiary base and improve profitability.

9 months ago - Transcripts

Rede D'Or São Luiz Earnings Call Transcript: Q1 2025

First quarter 2025 saw strong revenue, EBITDA, and net income growth, with robust cash generation and continued expansion of operational beds. SulAmérica added nearly 100,000 new beneficiaries, improved claims ratio, and maintained disciplined expenses.

1 year ago - Transcripts

Rede D'Or São Luiz Earnings Call Transcript: Q4 2024

Solid 2024 results with 10% revenue growth, 33% higher EBITDA, and 81.6% net income increase, driven by hospital expansion and SulAmérica's strong performance. Expecting accelerated bed growth and margin improvement in 2025, with continued focus on operational efficiency and product innovation.

1 year ago - Transcripts

Rede D'Or São Luiz Earnings Call Transcript: Q3 2024

Q3 2024 saw 9.1% revenue growth, margin expansion, and strong EBITDA, driven by higher average ticket and complex surgeries. SulAmérica improved its loss ratio and beneficiary base, while new hospital expansions and disciplined capital allocation support a positive 2025 outlook.

1 year ago - Transcripts

Rede D'Or São Luiz Earnings Call Transcript: Q2 2024

Q2 2024 saw record patient days, high occupancy, and strong revenue and EBITDA growth, with net income more than doubling YoY. New hospital launches and expansions are set to drive further growth, while SulAmérica improved its loss ratio and beneficiary base.

1 year ago - Transcripts